Author: Courtellemont, Laura; Guinard, jerome; Guillaume, Clemence; Giache, Susanna; Rzepecki, Vincent; Seve, Aymeric; Gubavu, Camelia; Baud, Kim; Helloco, Claire Le; Cassuto, Guy; Pialoux, Gilles; Hocqueloux, Laurent; prazuck, thierry
Title: Real-life performances of a novel antigen detection test on nasopharyngeal specimens for SARS-CoV-2 infection diagnosis: a prospective study Cord-id: y4trtefu Document date: 2020_1_1
ID: y4trtefu
Snippet: IntroductionThe SARS-CoV-2 pandemic has become a major public health issue worldwide. Developing and evaluating rapid and easy-to-perform diagnostic tests is an absolute priority. The current study was designed to assess diagnostic performances of an antigen-based rapid detection test (COVID-VIRO(R)) in a real-life setting. MethodsTwo nasopharyngeal specimens of symptomatic or asymptomatic adult patients hospitalized in the Infectious Diseases Department or voluntarily accessing the COVID-19 Scr
Document: IntroductionThe SARS-CoV-2 pandemic has become a major public health issue worldwide. Developing and evaluating rapid and easy-to-perform diagnostic tests is an absolute priority. The current study was designed to assess diagnostic performances of an antigen-based rapid detection test (COVID-VIRO(R)) in a real-life setting. MethodsTwo nasopharyngeal specimens of symptomatic or asymptomatic adult patients hospitalized in the Infectious Diseases Department or voluntarily accessing the COVID-19 Screening Department of the Regional Hospital of Orleans, France, were concurrently collected. COVID VIRO(R) diagnostic specificity and sensitivity were assessed in comparison to real-time reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) results. A subset of patients underwent an additional oropharyngeal and/or a saliva swab for rapid testing. Results121 patients already having a confirmed infection and 127 patients having no evidence of recent or ongoing infection were enrolled, for a total of 248 couple of nasopharyngeal swab specimens. Overall COVID-VIRO(R) sensitivity was 96.7% (IC: 93.5%-99.9%). In asymptomatic patients, symptomatic patients having symptoms for more than 4 days and those having a RT-qPCR Cycle threshold value [≥]32, sensitivity was of 100%, 95.8% and 91.9% respectively. The concordance between RT-qPCR and COVID VIRO(R) rapid test was 100% for the 127 patients with no SARS-CoV-2 infection. ConclusionCOVID-VIRO(R) test had 100% specificity and above 95% sensitivity, better than WHO recommendations (specificity [≥]97-100%, sensitivity [≥]80%). These rapid tests are particularly interesting for large-scale screening in Emergency Department, low resource settings and airports.
Search related documents:
Co phrase search for related documents- Try single phrases listed below for: 1
Co phrase search for related documents, hyperlinks ordered by date